A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Roswell Park Cancer Institute
Ohio State University Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Massachusetts General Hospital
Institute of Hematology & Blood Diseases Hospital, China
City of Hope Medical Center
Medical University of Gdansk
M.D. Anderson Cancer Center
Thomas Jefferson University
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
University of Rochester
Affiliated Hospital of Qinghai University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Hackensack Meridian Health
Mayo Clinic
Thomas Jefferson University
Fred Hutchinson Cancer Center
Radboud University Medical Center
Radboud University Medical Center
Advice Pharma Group srl
ASH Research Collaborative
National Cancer Institute (NCI)
Sanguine Biosciences
OHSU Knight Cancer Institute
Memorial Sloan Kettering Cancer Center
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
University Medical Center Groningen
M.D. Anderson Cancer Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
University of Virginia
Scripps Health
Scripps Health
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Bellicum Pharmaceuticals
OHSU Knight Cancer Institute
Celgene
Celgene
University of Utah
Rutgers, The State University of New Jersey
West Virginia University
University of Athens
Instituto de Investigacion Sanitaria La Fe
City of Hope Medical Center